In the pre-COVID-19 phase, all three pro-inflammatory genes (IL1β, IL6, and TNF) decreased to a statistically significant extent in both the groups by day 90; TNF, however, temporarily increased in Group II by day 5. The gene discussed is TNF; the disease is COVID-19.